NCT00341692View on ClinicalTrials.gov

Studying Normal Breast Tissue and Cancer Risk

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

April 7, 2003

Primary Completion Date

February 1, 2012

Study Completion Date

April 28, 2020

Conditions
Breast NeoplasmsNeoplasms by SiteNeoplasmsBreast DiseasesSkin Diseases
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00341692 - Studying Normal Breast Tissue and Cancer Risk | Biotech Hunter | Biotech Hunter